JunD-deficiency-derived ROS elevation enhances HIF-1α accumulation and stimulates the CXCL12/CXCR4 pathway, which activates RhoA-GTPase to promote myofibroblast differentiation in TME, facilitating tumor metastasis [195]. Here, HIF1A is linked to neoplasm.